In line with these results, we further confirmed that the fluoxetine could activate the ATF4-AKT-mTOR pathway to induce cell cycle arrest and autophagy to restraint cancer cells’ growth without affecting normal cells (Figure 9). The gene discussed is AKT1; the disease is cancer.